Results 161 to 170 of about 179,970 (275)

Comparison of Different Treatment Protocols in Postmenopausal Osteoporosis

open access: yes, 2005
This study was planned to compare the effects of three different treatment protocols including calcitonin, calcium and Vit D on bone mineral density (BMD) of postmenauposal women.
Zühal E. Altay   +4 more
core  

Osteoporosis Awareness and Knowledge in Postmenopausal Breast Cancer Survivors

open access: yes
Objective: To determine the awareness and knowledge levels of osteoporosis in postmenopausal breast cancer survivors (PBCS) who have completed adjuvant chemoradiotherapy, are under hormonal therapy, or are being monitored, and to examine potentially ...
Lale Aktekin   +4 more
core   +1 more source

Resveratrol: Advance on the Most Recent Research From 2021 to 2025

open access: yesPhytochemicals in Food and Medicine, Volume 1, Issue 3, September 2026.
This review summarizes recent progress in resveratrol research (2021–2025), highlighting its natural sources, bioactivities, clinical evidence, and safety profiles. Resveratrol exerts multi‐target effects through the regulation of oxidative stress, inflammation, mitochondrial function, and gut microbiota.
Quanyong Wu   +4 more
wiley   +1 more source

The Associations of Diabetes Mellitus and Obesity on Osteoporosis

open access: yesReproductive, Female and Child Health, Volume 5, Issue 3, September 2026.
ABSTRACT Objectives Osteoporosis is a common and debilitating condition that disproportionately affects older adults, particularly women, leading to increased fracture risk and reduced quality of life. While traditional risk factors such as age, hormonal changes, and lifestyle factors are well established, the impacts of diabetes and obesity on ...
Mendon G. Thomas   +1 more
wiley   +1 more source

The Effect of Bisphosphonate Treatment on Blood Lipid Parameters in Patients with Postmenopausal Osteoporosis

open access: yes, 2005
Bisphosphonates are currently the most preferred class of drugs used for the treatment of metabolic bone disease such as osteoporosis and Paget’s disease. Although their exact mechanism has not been identified, the compounds containing amino group (amino
Çiğdem Tüzün   +2 more
core  

‘I Would Rather Manage It on My Own’: Cultural Stigma, Silence and Barriers to Professional Healthcare‐Seeking for Menopause‐Related Symptoms Among Perimenopausal Women in Public Universities in Southern Nigeria

open access: yesReproductive, Female and Child Health, Volume 5, Issue 3, September 2026.
ABSTRACT Objective The menopausal transition remains a neglected area of women's health in sub‐Saharan Africa, often framed as a private, non‐medical life stage. This study investigates how cultural stigma, norms of silence and healthcare‐system factors shape professional healthcare‐seeking for menopause‐related symptoms among perimenopausal women ...
Ukie Seimokumo Angaye   +1 more
wiley   +1 more source

SGLT2 Inhibitors Are Associated With Suppression of the Sema3A/NRP1/Plexin‐A1 Signaling Axis in Postmenopausal Women With Type 2 Diabetes: Evidence From Propensity Score‐Matched Analysis

open access: yesJournal of Diabetes, Volume 18, Issue 9, September 2026.
Propensity score‐matched comparison of 23 SGLT2 inhibitor users and 23 non‐users revealed that SGLT2 inhibitor use was associated with significantly lower Neuropilin‐1 (NRP1) levels (74.25 vs. 87.61 ng/mL; p = 0.015) and a higher Sema3A/NRP1 ratio (0.14 vs.
Sertas Erarslan, Burcu Cosgun Bora
wiley   +1 more source

Home - About - Disclaimer - Privacy